Flow cytometric analysis to detect NK cells showed that approximately 60% (range: 3.7–96%) of hCD45+ cells in mice treated with CAR-NK-92 cells were CD56+, indicating that the anti-AML activity was associated with CAR-NK-92 cell persistence (Figure 4c,d). This evidence concerns the gene NCAM1 and acute myeloid leukemia.